Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ding Chuan Tang (DCT) is a traditional Chinese herbal decoction used primarily for the treatment of bronchial asthma and respiratory conditions characterized by wheezing, coughing, and phlegm. The formula is typically composed of nine herbs: *Ephedra sinica* (Ma Huang), *Ginkgo biloba* (Bai Guo), *Prunus armeniaca* (Xing Ren), *Morus alba* (Sang Bai Pi), *Perilla frutescens* (Su Zi), *Tussilago farfara* (Kuan Dong Hua), *Aster tataricus* (Zi Wan), *Scutellaria baicalensis* (Huang Qin), and *Glycyrrhiza uralensis* (Gan Cao). In traditional medicine, it is designed to diffuse the Lung, direct Qi downward, and clear heat. Modern clinical research indicates that DCT can improve airway hyper-responsiveness (AHR) and reduce airway inflammation in stabilized asthmatic children, potentially serving as an effective add-on complementary therapy. Its pharmacological effects are attributed to the synergistic action of its components, including bronchodilation from ephedrine and anti-inflammatory effects from baicalin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ding Chuan Tang.